Q2 2020 Holdings
Filed 2020-08-13 | 8 holdings | $112.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Myokardia, Inc. | COM | 62857M105 | $38.6K | 399,360 | 34.3% |
| Blueprint Medicines Corporation(2L9) | COM | 09627Y109 | $19.5K | 249,598 | 17.3% |
| Oric Pharmaceuticals, Inc.(ORIC) | COM | 68622P109 | $16.8K | 496,893 | 14.9% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $16.0K | 998,278 | 14.3% |
| Natera, Inc.(NTRA) | COM | 632307104 | $10.4K | 208,768 | 9.3% |
| Cymabay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $5.6K | 1,599,958 | 5.0% |
| Acceleron Pharma Inc.(XLRN) | COM | 00434H108 | $4.0K | 42,030 | 3.6% |
| FibroGen, Inc.(FGENEUR) | COM | 31572Q808 | $1.6K | 40,000 | 1.4% |